Stocks›Healthcare›FEMY

FEMY

Femasys Inc.
NasdaqResearch view
$2.48+2.06%
Sep 25 close · 1D EOD · Databento
HealthcareSurgical & Medical Instruments & ApparatusMicro-capSEC EDGAR FY 2025-12-31

The numbers · FY2025, filed

SEC EDGAR
Market cap$21M
Revenue$2.3M+40.80%
Net income$-18.6M
EPS, diluted$-0.47+44.70%
Operating margin-767.0%
Return on equity-317.4%
All filed figures

Snapshot

SEC EDGAR · FY 2025-12-31
SectorHealthcare
Market Cap$20.8M
Enterprise Value$11.5M
Income$-18.6M
Sales$2.3M
Book/sh$0.70
Cash/sh$1.11
Dividend TTM—
Payout—
Employees—
IPO—
Quick Ratio2.95
Current Ratio4.53
Debt/Eq—
EPS (ttm)$-0.47
EPS this Y44.7%
EPS past 3/5Y—
Sales past 3/5Y23.9%
EPS Y/Y TTM44.7%
Sales Y/Y TTM40.8%
Shs Outstand8.38M
ROA-89.9%
ROE-317.4%
ROIC—
Gross Margin—
Oper. Margin-767.0%
Profit Margin-812.3%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue by fiscal year

$1.2M
FY21
$1.2M
FY22
$1.1M
FY23
$1.6M
FY24
$2.3M
FY25

Operating leverage — margins

GrossOperatingNet
0%40%80%-767%-812%FY21FY22FY23FY24FY25
Financials, annual · income and cash flowSEC EDGAR · open ▸

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it
USDFY2021FY2022FY2023FY2024FY2025

Same industry

In the screener →

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.